ID: ALA5283229
Chembl Id: CHEMBL5283229
Max Phase: Preclinical
Molecular Formula: C13H4N4O2
Molecular Weight: 248.20
Associated Items:
Canonical SMILES: N#Cc1nc2c(nc1C#N)-c1ccc(O)cc1C2=O
Standard InChI: InChI=1S/C13H4N4O2/c14-4-9-10(5-15)17-12-11(16-9)7-2-1-6(18)3-8(7)13(12)19/h1-3,18H
Standard InChI Key: WWMOLNPIOMEHFL-UHFFFAOYSA-N
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Molecular Weight: 248.20 | Molecular Weight (Monoisotopic): 248.0334 | AlogP: 1.14 | #Rotatable Bonds: ┄ |
| Polar Surface Area: 110.66 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
| #RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
| CX Acidic pKa: 7.69 | CX Basic pKa: ┄ | CX LogP: 1.62 | CX LogD: 1.44 |
| Aromatic Rings: 2 | Heavy Atoms: 19 | QED Weighted: 0.64 | Np Likeness Score: 0.01 |
| 1. Li P, Liu HM.. (2020) Recent advances in the development of ubiquitin-specific-processing protease 7 (USP7) inhibitors., 191 [PMID:32092586] [10.1016/j.ejmech.2020.112107] |
Source(1):
